EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Characterization of the circulating markers of the renin-angiotensin-aldosterone system in telmisartan- or enalapril-treated dogs with proteinuric chronic kidney disease

Joanna E Murdoch iD, Bianca N Lourenço iD, Roy D Berghaus, Marisa K Ames iD, Hillary K Hammond, Amanda E Coleman iD

Journal of Veterinary Internal Medicine · 2024

DOI: 10.1111/jvim.17186 ↗

At a glance

Journal article in Journal of Veterinary Internal Medicine, 2024. Written by Joanna E Murdoch and 5 co-authors. Institution: Department of Small Animal and Surgery, University of Georgia College of Veterinary Medicine, Athens, Georgia, USA. Major MEDLINE topics: Telmisartan, Enalapril, Dog Diseases, Renin-Angiotensin System. Cited 2 times so far (Crossref); 54 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: University of Georgia College of Veterinary Medicine Department of Small Animal Medicine and Surgery, Translational RAAS Interest Group with support from Ceva Animal Health.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Effects of the renin-angiotensin-aldosterone system (RAAS) inhibitors enalapril and telmisartan on circulating RAAS in dogs with proteinuric chronic kidney disease (pCKD) are undescribed.

Objectives

To characterize the RAAS in untreated dogs with pCKD compared to healthy, life-stage- and sex-matched controls, and in dogs with pCKD after 30 days of treatment with enalapril or telmisartan. Animals Dogs with pCKD (n = 36) and healthy controls (n = 20).

Methods

Retrospective study of banked samples and previously collected data. Day 0 serum equilibrium concentrations of angiotensin I, II, III, IV, 1-5, and 1-7, and aldosterone, and urinary aldosterone-to-creatinine ratio (UACR) from pCKD dogs were compared to values on day 30 of treatment with enalapril (0.5 mg/kg PO q12) or telmisartan (1 mg/kg PO q24h) and to those of healthy dogs. Data were analyzed using linear mixed models.

Results

Compared with healthy dogs, pCKD dogs had significantly higher Ang I, III, 1-5, and 1-7 concentrations, and UACR. Relative to pretreatment values, day 30 Ang II concentrations were significantly increased and decreased in telmisartan- and enalapril-treated pCKD dogs, respectively (both P < .001). Mean (95% confidence interval) percentage change from pretreatment value in serum Ang 1-7 concentration was significantly greater in telmisartan- (753% [489%-1134%]) versus enalapril-treated (149% [69%-268%]) dogs (P < .001). Serum aldosterone decreased with treatment (P = .02 for enalapril, P < .001 for telmisartan), with no difference between groups at day 30. Conclusions and Clinical Importance Circulating RAAS activity is higher in dogs with pCKD. Compared with enalapril, treatment with telmisartan caused significantly greater increases in the presumed beneficial peptide Ang 1-7.

Subjects

MeSH terms (MEDLINE)

TelmisartanEnalaprilDog DiseasesRenin-Angiotensin SystemRenal Insufficiency, ChronicAngiotensin-Converting Enzyme InhibitorsAldosteroneAnimalsDogsMaleFemaleRetrospective StudiesBiomarkersProteinuriaCase-Control StudiesCreatinineAngiotensins

Author keywords

equilibrium analysishealthy dogsliquid chromatography‐mass spectrometryrenal proteinuriaurinary aldosterone‐to‐creatinine ratio

Substances

TelmisartanEnalaprilAngiotensin-Converting Enzyme InhibitorsAldosteroneBiomarkersCreatinineAngiotensins

Authors and institutions

  • Department of Small Animal and Surgery, University of Georgia College of Veterinary Medicine, Athens, Georgia, USA.
  • Department of Population Health, University of Georgia College of Veterinary Medicine, Athens, Georgia, USA.
  • Department of Medicine and Epidemiology, University of California, Davis School of Veterinary Medicine, Davis, California, USA.
  • Department of Clinical Sciences, Colorado State University College of Veterinary Medicine and Biomedical Sciences, Fort Collins, Colorado, USA.

ORCID profiles: Joanna E Murdoch, Bianca N Lourenço, Marisa K Ames, Amanda E Coleman

Funding

  • University of Georgia College of Veterinary Medicine Department of Small Animal Medicine and Surgery
  • Translational RAAS Interest Group with support from Ceva Animal Health

Cite

APA

Murdoch, J. E., Lourenço, B. N., Berghaus, R. D., Ames, M. K., Hammond, H. K., & Coleman, A. E. (2024). Characterization of the circulating markers of the renin-angiotensin-aldosterone system in telmisartan- or enalapril-treated dogs with proteinuric chronic kidney disease. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17186

Vancouver

Murdoch JE, Lourenço BN, Berghaus RD, Ames MK, Hammond HK, Coleman AE. Characterization of the circulating markers of the renin-angiotensin-aldosterone system in telmisartan- or enalapril-treated dogs with proteinuric chronic kidney disease. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17186

BibTeX
@article{Murdoch2024,
  author = {Murdoch, Joanna E and Lourenço, Bianca N and Berghaus, Roy D and Ames, Marisa K and Hammond, Hillary K and Coleman, Amanda E},
  title = {Characterization of the circulating markers of the renin-angiotensin-aldosterone system in telmisartan- or enalapril-treated dogs with proteinuric chronic kidney disease},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  doi = {10.1111/jvim.17186}
}
Start for free →